1188 related articles for article (PubMed ID: 8899312)
1. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies.
Sotomayor EM; Rao K; Lopez DM; Liepins A
Drugs Exp Clin Res; 1992; 18 Suppl():5-11. PubMed ID: 1305044
[TBL] [Abstract][Full Text] [Related]
3. Activation of spleen cell lytic activity by the alkaloid thiophosphoric acid derivative: Ukrain.
Liepins A; Nowicky JW
Int J Immunopharmacol; 1992 Nov; 14(8):1437-42. PubMed ID: 1464476
[TBL] [Abstract][Full Text] [Related]
4. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
[TBL] [Abstract][Full Text] [Related]
5. Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation.
Cordes N; Plasswilm L; Bamberg M; Rodemann HP
Int J Radiat Biol; 2002 Jan; 78(1):17-27. PubMed ID: 11747550
[TBL] [Abstract][Full Text] [Related]
6. Macrophage stimulation and antitumor effect of Ukrain.
Korolenko TA; Svechnikova IG; Filjushina EE; Kaledin VI; Vakulin GM; Usynin IF; Tsyrendordjiev DD
Drugs Exp Clin Res; 1998; 24(5-6):253-60. PubMed ID: 10190084
[TBL] [Abstract][Full Text] [Related]
7. Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice.
Grinevich Y; Shalimov S; Bendyuh G; Zahriychuk O; Hodysh Y
Drugs Exp Clin Res; 2005; 31(2):59-70. PubMed ID: 15929607
[TBL] [Abstract][Full Text] [Related]
8. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V
BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634
[TBL] [Abstract][Full Text] [Related]
9. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
Leu RW; Leu NR; Shannon BJ; Fast DJ
J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
[TBL] [Abstract][Full Text] [Related]
10. Induction of tumor-inhibitory macrophages with a novel synthetic immunomodulator, 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738).
Wang BS; Lumanglas AL; Ruszala-Mallon VM; Durr FE
J Immunol; 1985 Jul; 135(1):679-83. PubMed ID: 3839006
[TBL] [Abstract][Full Text] [Related]
11. Ukrain (NSC-631570) in experimental and clinical studies: a review.
Jagiello-Wójtowicz E; Kleinrok Z; Urbanska EM
Drugs Exp Clin Res; 1998; 24(5-6):213-9. PubMed ID: 10190077
[TBL] [Abstract][Full Text] [Related]
12. Action of Ukrain, a cytostatic and immunomodulating drug, on effects of irradiation.
Boyko VN; Voltchek IV; Petrov AS; Bubnov VP
Drugs Exp Clin Res; 1996; 22(3-5):167-71. PubMed ID: 8899323
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory activity of polysaccharides isolated from Strongylocentrotus nudus eggs.
Liu C; Xi T; Lin Q; Xing Y; Ye L; Luo X; Wang F
Int Immunopharmacol; 2008 Dec; 8(13-14):1835-41. PubMed ID: 18834960
[TBL] [Abstract][Full Text] [Related]
14. In-vitro toxicity of Ukrain against human Ewing tumor cell lines.
Lanvers-Kaminsky C; Nolting DM; Köster J; Schröder A; Sandkötter J; Boos J
Anticancer Drugs; 2006 Oct; 17(9):1025-30. PubMed ID: 17001175
[TBL] [Abstract][Full Text] [Related]
15. Role of tumor necrosis factor in macrophage activation and tumoricidal activity.
Mace KF; Ehrke MJ; Hori K; Maccubbin DL; Mihich E
Cancer Res; 1988 Oct; 48(19):5427-32. PubMed ID: 3416299
[TBL] [Abstract][Full Text] [Related]
16. Restoration of lipopolysaccharide-mediated cytotoxic macrophage induction in C3H/HeJ mice by interferon-gamma or a calcium ionophore.
Akagawa KS; Kamoshita K; Onodera S; Tokunaga T
Jpn J Cancer Res; 1987 Mar; 78(3):279-87. PubMed ID: 3106284
[TBL] [Abstract][Full Text] [Related]
17. [Experimental analysis of cytotoxicity mediated by activated macrophages against glioma cells in mice].
Ohyama K
Nihon Geka Hokan; 1993 Mar; 62(2):92-115. PubMed ID: 8239865
[TBL] [Abstract][Full Text] [Related]
18. Effect of tumour growth on the macrophage response to the antitumour agent 5,6-dimethylxanthenone-4-acetic acid.
Ching LM; Joseph WR; Baguley BC
Anticancer Res; 1993; 13(6A):2069-75. PubMed ID: 8297115
[TBL] [Abstract][Full Text] [Related]
19. Tumoricidal activation of murine resident peritoneal macrophages by interleukin 2 and tumor necrosis factor alpha.
Verstovsek S; Maccubbin D; Ehrke MJ; Mihich E
Cancer Res; 1992 Jul; 52(14):3880-5. PubMed ID: 1617664
[TBL] [Abstract][Full Text] [Related]
20. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
Fernandez-Cruz E; Ulich T; Schreiber RD
J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]